What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?

BenzingaSep 6 09:35 ET

100% of cancer patients successfully implanted with Vor Bio (VOR.US) innovative therapy will soon enter a critical trial.

Recently, Vor Bio announced the combination of its investigational stem cell therapy tremtelectogene empogeditemcel (trem-cel) with the CD33-targeted antibody-drug conjugate (ADC) Mylotarg.

Zhitong FinanceSep 7 03:50 ET

Sector Update: Health Care Stocks Drop Friday Afternoon

MT NewswiresSep 6 13:50 ET

Sector Update: Health Care

MT NewswiresSep 6 13:32 ET

Vor Biopharma Price Target Maintained With a $12.00/Share by JMP Securities

Dow JonesSep 6 11:02 ET · Ratings

Evercore Initiates Vor Biopharma(VOR.US) With Buy Rating

Moomoo NewsSep 6 08:31 ET · Ratings